Finch Therapeutics Group Stock Price on March 31, 2022
| FNCH Stock | USD 2.03 0.32 13.62% |
If you're considering investing in Finch Stock, it is important to understand the factors that can impact its price. As of today, the current price of Finch Therapeutics stands at 2.03, as last reported on the 16th of April 2024, with the highest price reaching 2.41 and the lowest price hitting 1.86 during the day. Finch Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0538, which denotes the company had a -0.0538% return per unit of risk over the last 3 months. Finch Therapeutics Group exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Finch Therapeutics' Mean Deviation of 4.29, standard deviation of 7.0, and Variance of 49.06 to check the risk estimate we provide.
As of now, Finch Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Finch Therapeutics' current Liabilities And Stockholders Equity is estimated to increase to about 116.5 M, while Common Stock Total Equity is projected to decrease to 6,400. . As of now, Finch Therapeutics' Price To Book Ratio is increasing as compared to previous years. The Finch Therapeutics' current Price Sales Ratio is estimated to increase to 75.01, while Price Earnings Ratio is projected to decrease to (0.08). Finch Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Finch |
Sharpe Ratio = -0.0538
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FNCH |
Estimated Market Risk
| 7.21 actual daily | 63 63% of assets are less volatile |
Expected Return
| -0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Finch Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Finch Therapeutics by adding Finch Therapeutics to a well-diversified portfolio.
Price Book 0.1424 | Enterprise Value Ebitda (0.25) | Price Sales 30.4644 | Shares Float 792.9 K | Wall Street Target Price 90 |
Finch Therapeutics Valuation on March 31, 2022
It is possible to determine the worth of Finch Therapeutics on a given historical date. On March 31, 2022 Finch was worth 5.0 at the beginning of the trading date compared to the closed value of 141.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Finch Therapeutics stock. Still, in general, we apply an absolute valuation method to find Finch Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Finch Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Finch Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
04/01/2022 | 5.00 | 141.60 | 141.60 | 141.60 | 2,022 |
| 4.71 | 153.30 | 153.30 | 153.30 | 1,382 |
| Backtest Finch Therapeutics | | | Finch Therapeutics History | | | Finch Therapeutics Valuation | Next |
Finch Therapeutics Trading Date Momentum on March 31, 2022
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Finch Therapeutics Fundamentals Correlations and Trends
By evaluating Finch Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Finch Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Finch financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Finch Therapeutics Stock history
Finch Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Finch is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Finch Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Finch Therapeutics stock prices may prove useful in developing a viable investing in Finch Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.6 M | 1.3 M | |
| Net Loss | -103.2 M | -98 M |
Finch Therapeutics Quarterly Net Working Capital |
|
Finch Therapeutics Stock Technical Analysis
Finch Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Finch Therapeutics Period Price Range
Low | April 1, 2022
| High |
5.00 | 141.60 |
Finch Therapeutics April 16, 2024 Market Strength
Market strength indicators help investors to evaluate how Finch Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Finch Therapeutics shares will generate the highest return on investment. By undertsting and applying Finch Therapeutics stock market strength indicators, traders can identify Finch Therapeutics Group entry and exit signals to maximize returns
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 28.32 | |||
| Day Median Price | 141.6 | |||
| Day Typical Price | 141.6 | |||
| Price Action Indicator | 68.3 | |||
| Period Momentum Indicator | (139.57) |
Finch Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Finch Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Finch Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Finch to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.52) | |||
| Total Risk Alpha | (1.11) | |||
| Treynor Ratio | (3.93) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Finch Therapeutics Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Finch Therapeutics information on this page should be used as a complementary analysis to other Finch Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Finch Stock analysis
When running Finch Therapeutics' price analysis, check to measure Finch Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Finch Therapeutics is operating at the current time. Most of Finch Therapeutics' value examination focuses on studying past and present price action to predict the probability of Finch Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Finch Therapeutics' price. Additionally, you may evaluate how the addition of Finch Therapeutics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Finch Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Finch Therapeutics. If investors know Finch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Finch Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (46.59) | Revenue Per Share 0.067 | Quarterly Revenue Growth (1.00) | Return On Assets (0.19) | Return On Equity (1.26) |
The market value of Finch Therapeutics is measured differently than its book value, which is the value of Finch that is recorded on the company's balance sheet. Investors also form their own opinion of Finch Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Finch Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Finch Therapeutics' market value can be influenced by many factors that don't directly affect Finch Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Finch Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Finch Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Finch Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.